NovoCure Ltd Insider Trading for March 2020

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NovoCure Ltd.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NovoCure Ltd for March 2020.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 10 2020NVCRNovoCure LtdAmbrogi Michael J.Chief Operating Off ...SellS69.532,274158,120220,867223.1 K to 220.9 K (-1.02 %)
Mar 10 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseM7.4817,500130,90014,518
Mar 10 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS64.273,245208,556100,693103.9 K to 100.7 K (-3.12 %)
Mar 10 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...BuyM7.4817,500130,900103,93886.4 K to 103.9 K (+20.25 %)
Mar 10 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS69.532,906202,06686,43889.3 K to 86.4 K (-3.25 %)
Mar 10 2020NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS69.534,320300,387510,511514.8 K to 510.5 K (-0.84 %)
Mar 10 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...SellS69.533,123217,155140,386143.5 K to 140.4 K (-2.18 %)
Mar 06 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseG21.901,64436,0041,644
Mar 06 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseG21.90298,3866,534,653298,386
Mar 06 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseG21.90300,0306,570,6570
Mar 06 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseG7.15219,3731,568,517219,373
Mar 06 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseG7.15219,3731,568,5170
Mar 06 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseG21.1584,4831,786,81584,483
Mar 06 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseG21.1584,4831,786,8150
Mar 05 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseA69.3741,6902,892,03541,690
Mar 05 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...GrantA0.0021,623089,34467.7 K to 89.3 K (+31.93 %)
Mar 05 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseA69.3746,3233,213,42746,323
Mar 05 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...GrantA0.0024,0250143,509119.5 K to 143.5 K (+20.11 %)
Mar 05 2020NVCRNovoCure LtdAmbrogi Michael J.Chief Operating Off ...Option ExerciseA69.3727,7941,928,07027,794
Mar 05 2020NVCRNovoCure LtdAmbrogi Michael J.Chief Operating Off ...GrantA0.0014,4150223,141208.7 K to 223.1 K (+6.91 %)
Mar 05 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA69.3737,0582,570,71337,058
Mar 05 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA0.0019,220089,25270 K to 89.3 K (+27.44 %)
Mar 05 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseA69.3727,7941,928,07027,794
Mar 05 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...GrantA0.0014,415030,03215.6 K to 30 K (+92.30 %)
Mar 05 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS72.971,485108,36067,72169.2 K to 67.7 K (-2.15 %)
Mar 02 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseM0.003,08603,086
Mar 02 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS72.221,601115,61669,20670.8 K to 69.2 K (-2.26 %)
Mar 02 2020NVCRNovoCure LtdShah PriteshChief Commercial Of ...BuyM79.453,086245,18370,80767.7 K to 70.8 K (+4.56 %)
Mar 02 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...Option ExerciseM0.007,71607,716
Mar 02 2020NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Financial Off ...BuyM0.007,7160119,484111.8 K to 119.5 K (+6.90 %)
Mar 02 2020NVCRNovoCure LtdAmbrogi Michael J.Chief Operating Off ...Option ExerciseM0.006,17306,172
Mar 02 2020NVCRNovoCure LtdAmbrogi Michael J.Chief Operating Off ...SellS72.222,673193,031208,726211.4 K to 208.7 K (-1.26 %)
Mar 02 2020NVCRNovoCure LtdAmbrogi Michael J.Chief Operating Off ...BuyM79.456,173490,445211,399205.2 K to 211.4 K (+3.01 %)
Mar 02 2020NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanOption ExerciseM0.009,25909,259
Mar 02 2020NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS72.223,893281,133514,831518.7 K to 514.8 K (-0.75 %)
Mar 02 2020NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanBuyM79.459,259735,628518,724509.5 K to 518.7 K (+1.82 %)
Mar 02 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM0.005,55605,555
Mar 02 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS72.222,643190,86470,03272.7 K to 70 K (-3.64 %)
Mar 02 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM79.455,556441,42472,67567.1 K to 72.7 K (+8.28 %)

Contact us | Follow us on Twitter